drug development through acquisition of late stage pre-clinical or early stage clinical compounds

History:

BioPharmaceutics was founded in 1991. They changed their name to Cytoclonal Pharmaceutics in 1992 and then to eXegenics in 2001.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Texas

Research Focus:
Disease Therapeutics-Development Therapeutics-Clinical early (I, II)

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: